Capitolis Liquid Global Markets LLC Abb Vie Inc. Transaction History
Capitolis Liquid Global Markets LLC
- $9.43 Trillion
- Q3 2024
A detailed history of Capitolis Liquid Global Markets LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 810,000 shares of ABBV stock, worth $147 Million. This represents 1.7% of its overall portfolio holdings.
Number of Shares
810,000
Previous 40,000
1925.0%
Holding current value
$147 Million
Previous $6.86 Billion
2231.49%
% of portfolio
1.7%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
3,849Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$31.2 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.46 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.03 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $321B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...